Peptide RX

back to claim graph

proof receipt / target

MTNR1A

Melatonin receptor 1A

grade B status sleep_circadian receipt 48b093dc77c8 proof 33%

what this node claims

MTNR1A

Melatonin receptor 1A

Open source surface

vertical proof spine

  1. 01 MTNR1A target / grade B / 70% 1 debt
  2. 02 MTNR1A WT fold / grade B / 70% 2 debt

evidence / risk instrument

44%
thin proof
structure evidence gates risk export lineage 44
low debt pressure 21%
28%structuredebt
pLDDT pending
78%evidenceusable
grade B
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
33%lineagedebt
incomplete spine

proof completeness

33% missing alphafold_metric, candidate, finding, export
  1. 01 target
  2. 02 fold
  3. 03 alphafold metric
  4. 04 candidate
  5. 05 finding
  6. 06 export

Metrics and receipt inputs

binding partners
    context annotations
    0
    family
    GPCR_class_A
    functional sites
      gene symbol
      MTNR1A
      go terms
        uniprot
        P48039

        AlphaFold metrics visual

        Confident backbone model

        85.7

        350 residues / min 31.48 / max 98.56 / source alphafold db

        PAE matrix for linked target
        Very high 68.3% 239 residues / >=90
        Confident 14.9% 52 residues / 70-89
        Low 6.3% 22 residues / 50-69
        Very low 10.6% 37 residues / <50

        usable fold context with explicit model-confidence limits

        Near-complete coverage / observed 350 of 350 residues.

        • residues 318-350 / mean 51.52
        • residues 1-21 / mean 39.9
        • residues 225-228 / mean 64.66
        • residues 223-223 / mean 66.19
        proof debt register

        Visible limits, not hidden cleanup.

        21%

        Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.

        medium missing functional-site annotations link target annotation, GO term, or binding-site context
        low computational-only status add independent evidence, challenge result, or witness review before strengthening
        medium no candidate yet leave visible until a stronger public receipt resolves it

        weakness and challenge edges

        What would stop this from becoming stronger.

        debt severity export claim strength next proof needed
        missing functional-site annotations medium visible weakens link target annotation, GO term, or binding-site context
        computational-only status low visible watch add independent evidence, challenge result, or witness review before strengthening
        no candidate yet medium visible weakens leave visible until a stronger public receipt resolves it

        what supports it

        No upstream proof edge yet.

        what it supports

        target has structure prediction target:94a610ac-d1e3-4815-9569-e401a92abc35 -> fold:3f539ad6-4d5b-4fa2-bb4a-990ba26dcfee folds_to / B / 0.857

        Research-use boundary

        This receipt describes public computational research state. It does not expose raw candidate sequences and does not make a clinical claim.